Document is current
Any future updates will be listed below
-
Authors
Ogier du Terrail, Jean https://orcid.org/0000-0001-6320-819X
Leopold, Armand https://orcid.org/0000-0002-5909-2689
Joly, Clément
Béguier, Constance
Andreux, Mathieu https://orcid.org/0000-0001-5778-9979
Maussion, Charles
Schmauch, Benoît https://orcid.org/0000-0002-9478-6395
Tramel, Eric W.
Bendjebbar, Etienne
Zaslavskiy, Mikhail
Wainrib, Gilles
Milder, Maud
Gervasoni, Julie
Guerin, Julien https://orcid.org/0000-0002-3024-8483
Durand, Thierry https://orcid.org/0000-0003-3861-8394
Livartowski, Alain
Moutet, Kelvin
Gautier, Clément
Djafar, Inal
Moisson, Anne-Laure
Marini, Camille
Galtier, Mathieu
Balazard, Félix
Dubois, Rémy
Moreira, Jeverson https://orcid.org/0000-0003-3478-7158
Simon, Antoine
Drubay, Damien https://orcid.org/0000-0002-9997-9727
Lacroix-Triki, Magali https://orcid.org/0000-0002-6641-8536
Franchet, Camille
Bataillon, Guillaume
Heudel, Pierre-Etienne https://orcid.org/0000-0002-2155-549X
-
Funding
Funding for this research was provided by:
Owkin Inc.
Institut Curie
Centre Léon Bérard
Institut Gustave Roussy
Oncopole Toulouse
- License Information
-
More Information
Article History
Received: 20 May 2021
Accepted: 23 November 2022
First Online: 19 January 2023
Competing interests
: The authors declare the existence of a financial competing interest. As described in the Acknowledgements section, this work received the financial support of the French Banque Publique d’Investissement (BPI) through the HealthChain project (). Some authors are or were employed by Owkin, Inc. during their time on the project (J.O.d.T., C.B., M.A., C. Maussion, B.S., E.B., M.Z., G.W., K.M., C.G., I.D., A.- L.M., C. Marini, M.G., J.M., R.D., A.S. and F.B.). In addition, G.W. is the cofounder of Owkin, Inc. P.E.H. reports grants, personal fees and nonfinancial support from Pfizer; grants and nonfinancial support from Novartis; grants and nonfinancial support from Roche; grants, personal fees and nonfinancial support from AstraZeneca; personal fees and nonfinancial support from Mylan; grants, personal fees, and nonfinancial support from Pierre Fabre; personal fees and nonfinancial support from Amgen; and personal fees and nonfinancial support from Seagen outside the submitted work.
